CMAB009 Combined With FOLFIRI First-line Treatment in Patients With RAS/BRAF Wild-type, Metastatic Colorectal Cancer
Clinical trial NCT03206151 · COMPLETED
Trial details
- NCT number
- NCT03206151
- Sponsor
- Taizhou Mabtech Pharmaceutical Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-12
- Primary completion
- 2022-05-06
- Enrollment
- 520
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.